Ultra Levure 200mg Saccharomyces Boulardii 30

Ultra Levure 200 mg – 30 Capsules

Probiotic Yeast Supplement for Digestive Regularity & Immune Support

Ultra Levure is a pharmaceutical-grade probiotic containing Saccharomyces boulardii CNCM I‑745—a well-researched yeast strain designed to manage diarrhea, support gut health during antibiotic use, and help maintain a balanced digestive flora.

🌿 What Is It?

Each capsule delivers 200 mg live S. boulardii—a non-pathogenic yeast that survives stomach acid and acts in the intestine, promoting digestive balance and reducing gut inflammation .

— Form: Freeze-dried yeast in a gelatin capsule
— Recommended for adults and children over 2 years .

✅ Key Benefits

• Supports watery or antibiotic-associated diarrhea, reducing symptom duration and recurrence .

• Helps prevent travelers’ diarrhea—effective when started 5 days before and continued during travel .

• May alleviate symptoms of IBS, IBD, and H. pylori treatment-related diarrhea.

• Enhances gut immune defense by blocking pathogen toxins, supporting the intestinal barrier, and modulating inflammation .

🕒 How to Use

• Adults & children ≥ 2 years: 1 capsule daily (200 mg), swallowed whole with water .

• For more severe diarrhea or travelers’ situations, dosages up to 250–500 mg two–four times daily have been studied .

• Duration: Typically 2–4 weeks; longer use for C. difficile prevention or chronic gut conditions may require medical oversight .

⚠️ Precautions & Warnings

• Avoid use in immunocompromised patients or those with central venous catheters due to rare risk of fungemia, though cases are extremely rare .

• Not recommended for infants under 2 years .

• May interact with antifungal medications—consult your doctor if you are on antifungal therapy .

• Stop use and seek medical advice if fever, blood in stool, severe abdominal pain, or symptoms persist beyond 2 days in children or adults.

📚 Evidence & Clinical Insight

• A 2015 meta-analysis of 21 RCTs (4,780 participants) found S. boulardii significantly reduces antibiotic-associated diarrhea .

• Evidence also highlights its benefit in reducing recurrence of C. difficile colitis, travelers’ diarrhea, and improving outcomes in IBS/IBD .

• Mechanisms include toxin degradation, immune stimulation, and competitive inhibition of pathogens .